{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:54:28Z","timestamp":1789401268326,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":1203,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1111\/ajt.15319","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T10:25:46Z","timestamp":1550226346000},"page":"2342-2349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Abatacept as rescue immunosuppression after calcineurin inhibitor treatment failure in renal transplantation"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6696-318X","authenticated-orcid":false,"given":"Idelberto Raul","family":"Badell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta M.","family":"Karadkhele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payaswini","family":"Vasanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Alton Brad","family":"Farris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1111\/ajt.15319_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJM198401193100303","article-title":"Cyclosporine: five years\u2019 experience in cadaveric renal transplantation","volume":"310","author":"Merion","year":"1984","journal-title":"N Engl J Med."},{"issue":"7","key":"10.1111\/ajt.15319_bib2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group","volume":"63","author":"Pirsch","year":"1997","journal-title":"Transplantation."},{"issue":"9","key":"10.1111\/ajt.15319_bib3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1111\/ajt.15319_bib4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant."},{"issue":"suppl 1","key":"10.1111\/ajt.15319_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ajt.14557","article-title":"OPTN\/SRTR 2016 annual data report: kidney","volume":"18","author":"Hart","year":"2018","journal-title":"Am J Transplant."},{"issue":"6","key":"10.1111\/ajt.15319_bib6","first-page":"3105","article-title":"Adverse effects associated with the use of FK 506","volume":"23","author":"Fung","year":"1991","journal-title":"Transplant Proc."},{"issue":"7","key":"10.1111\/ajt.15319_bib7","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/ajt.13710","article-title":"Calcineurin inhibitor minimization, conversion, withdrawal, and avoidance strategies in renal transplantation: a systematic review and meta-analysis","volume":"16","author":"Sawinski","year":"2016","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15319_bib8","first-page":"CD006750","article-title":"Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients","volume":"7","author":"Karpe","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"issue":"7","key":"10.1111\/ajt.15319_bib9","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"10","author":"Noris","year":"2010","journal-title":"Am J Transplant."},{"issue":"6","key":"10.1111\/ajt.15319_bib10","first-page":"3175","article-title":"Neurologic complications of FK 506","volume":"23","author":"Eidelman","year":"1991","journal-title":"Transplant Proc."},{"issue":"24","key":"10.1111\/ajt.15319_bib11","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med."},{"issue":"7","key":"10.1111\/ajt.15319_bib12","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/ajt.14186","article-title":"Early conversion from calcineurin inhibitor- to everolimus-based therapy following kidney transplantation: results of the randomized ELEVATE trial","volume":"17","author":"de Fijter","year":"2017","journal-title":"Am J Transplant."},{"issue":"11","key":"10.1111\/ajt.15319_bib13","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1097\/TP.0000000000000748","article-title":"Subclinical lesions and donor-specific antibodies in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen followed by early conversion to Sirolimus","volume":"99","author":"de Sandes-Freitas","year":"2015","journal-title":"Transplantation."},{"issue":"7","key":"10.1111\/ajt.15319_bib14","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1681\/ASN.2004100844","article-title":"Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study","volume":"16","author":"Abramowicz","year":"2005","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"10.1111\/ajt.15319_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","author":"Schena","year":"2009","journal-title":"Transplantation."},{"issue":"4","key":"10.1111\/ajt.15319_bib16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1111\/ajt.15319_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1053\/j.ajkd.2016.09.021","article-title":"Safety and efficacy outcomes 3 years after switching to belatacept from a calcineurin inhibitor in kidney transplant recipients: results from a phase 2 randomized trial","volume":"69","author":"Grinyo","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"9","key":"10.1111\/ajt.15319_bib18","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1016\/j.transproceed.2014.07.003","article-title":"Conversion to belatacept-based immunosuppression therapy in renal transplant patients","volume":"46","author":"Paz","year":"2014","journal-title":"Transplant Proc."},{"issue":"10","key":"10.1111\/ajt.15319_bib19","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1111\/ajt.13322","article-title":"Safe conversion from tacrolimus to belatacept in high immunologic risk kidney transplant recipients with allograft dysfunction","volume":"15","author":"Gupta","year":"2015","journal-title":"Am J Transplant."},{"issue":"7","key":"10.1111\/ajt.15319_bib20","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/ajt.13698","article-title":"Effect of an early switch to belatacept among calcineurin inhibitor-intolerant graft recipients of kidneys from extended-criteria donors","volume":"16","author":"Le Meur","year":"2016","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15319_bib21","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1056\/NEJMe1515765","article-title":"The clearer BENEFITS of belatacept","volume":"374","author":"Heher","year":"2016","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1111\/ajt.15319_bib22","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/TP.0b013e31819b5a58","article-title":"Assessment of belatacept-mediated costimulation blockade through evaluation of CD80\/86-receptor saturation","volume":"87","author":"Latek","year":"2009","journal-title":"Transplantation."},{"issue":"3","key":"10.1111\/ajt.15319_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1600-6143.2005.00749.x","article-title":"Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties","volume":"5","author":"Larsen","year":"2005","journal-title":"Am J Transplant."},{"issue":"20","key":"10.1111\/ajt.15319_bib24","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMoa035075","article-title":"Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig","volume":"349","author":"Kremer","year":"2003","journal-title":"N Engl J Med."},{"issue":"9636","key":"10.1111\/ajt.15319_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet."},{"issue":"16","key":"10.1111\/ajt.15319_bib26","doi-asserted-by":"crossref","first-page":"8789","DOI":"10.1073\/pnas.94.16.8789","article-title":"CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates","volume":"94","author":"Kirk","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"issue":"11","key":"10.1111\/ajt.15319_bib27","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.4049\/jimmunol.159.11.5187","article-title":"Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation","volume":"159","author":"Levisetti","year":"1997","journal-title":"J Immunol."},{"issue":"9","key":"10.1111\/ajt.15319_bib28","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/annrheumdis-2016-210724","article-title":"Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis","volume":"76","author":"Mease","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1111\/ajt.15319_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1600-065X.2003.00081.x","article-title":"Crossing the bridge: large animal models in translational transplantation research","volume":"196","author":"Kirk","year":"2003","journal-title":"Immunol Rev."},{"issue":"10","key":"10.1111\/ajt.15319_bib30","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/art.30463","article-title":"Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate","volume":"63","author":"Genovese","year":"2011","journal-title":"Arthritis Rheum."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15319","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15319","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15319","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522091997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522091997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:24:55Z","timestamp":1761629095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522091997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1600613522091997"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15319","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abatacept as rescue immunosuppression after calcineurin inhibitor treatment failure in renal transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}